03.11.2015 • News

DuPont Reorganizes, Completes Neoprene Sale

DuPont’s interim CEO Edward Breen, who took the helm following the resignation of long-time CEO Ellen Kullman in mid-October, has lost no time in streamlining the chemical giant’s activities.

The changes, which will become effective on Jan. 1, 2016, will create greater efficiency and enhanced capabilities while improving economies of scale and leading to more effective deployment of capital, the US group said. The number of reporting segments will be left unchanged at six.

Plans call for the Packaging & Industrial Polymers business unit to be combined with the Performance Polymers unit into a Performance Materials reporting segment, to be headed by Patrick E. Lindner, who currently heads Performance Polymers. Products include polyamide and polyester resins.

The Protection Technologies unit, which encompasses the high-tech Aramid fiber among other products, will be combined with Building Innovations into a single business unit that will be called Protection and headed by Rose Lee. It will be part of the existing Safety & Protection segment, which also includes Sustainable Solutions.

DuPont meanwhile has completed the sale of its chloroprene rubber business at La Place, Louisiana, USA, to Japan’s Denka Performance Elastomer. The deal, which was announced in December last year, was finalized on Oct. 31.

Denka said it successfully started up the chloroprene rubber plant at the site on Nov. 1. The US plant is the second chloroprene rubber facility for Denka which also operates a plant in Omi, Niigata prefecture.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.